Fig. 3.
Proportion of patients achieving target exposure in cycle 1 with SC vs IV trastuzumab by BMI in real-world practice. Target exposure was Cmin before cycle 2 ≥ 20 μg/mL. Adapted from [38].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.